Workers’ Compensation MSP Outcomes & Regulatory Insights Report

June 16, 2026

2022-2025 Performance Analysis

One of the most comprehensive multi-year MSP outcome analyses available in the workers’ compensation industry.

Executive Summary

Tower MSA Partners is pleased to provide this first-of-its-kind report, offering one of the most comprehensive multi-year MSP outcome analyses available in the industry. The report provides wide-ranging data points and key metrics across MSA services, conditional payment programs, and CMS-published benchmarks.

These outcomes reflect an integrated model that combines clinical engagement, disciplined allocation methodology, CMS alignment controls, pharmacy mitigation strategies, and aggressive conditional payment resolution.

This report presents aggregated, anonymized performance metrics from 2022 through 2025 to serve as directional benchmarks for workers’ compensation stakeholders evaluating their Medicare Secondary Payer strategy.

Key Findings

Between 2022 and 2025, Tower MSA Partners delivered measurable, repeatable reductions in Medicare-related settlement exposure while maintaining disciplined alignment with CMS expectations.

Across this four-year period:

  • 33% to 64% annual reduction in projected MSA amounts through clinical intervention
  • $9 million to $12 million in annual MSA-related savings generated through physician and pharmacy optimization
  • 23% lower CMS-approved MSAs compared to CMS national averages
  • 84% to 90% of submissions avoided development letters
  • 82% of conditional payment demands reduced to $0 in 2025
  • Three-day average turnaround time once documentation is complete

In 2025 alone:

  • Average CMS-approved Tower WCMSA: $67,692
  • CMS national average WCMSA: $86,169
  • Average savings differential per file: $18,477

Why This Matters

Medicare Secondary Payer strategy is no longer simply a compliance requirement. It directly impacts settlement velocity, reserve accuracy, pharmacy exposure, and overall financial predictability.

The outcomes presented in this report demonstrate that a disciplined MSP framework can materially improve both operational and financial performance. Organizations that combine clinical oversight, pharmacy management, documentation discipline, and regulatory expertise are better positioned to achieve compliant and cost-effective settlement outcomes.

What’s Included in the Report

  • Multi-year MSP performance benchmarks
  • Medicare Set-Aside outcome analysis
  • CMS approval and development metrics
  • Pharmacy and opioid mitigation outcomes
  • Conditional payment resolution trends
  • Regulatory developments impacting workers’ compensation
  • Settlement optimization insights
  • Industry benchmark data from 2022-2025

Access detailed benchmarks, regulatory developments, CMS trends, and performance metrics from 2022 through 2025.